Thrivable
Thrivable is a B2B SaaS healthcare market research platform serving pharma, medtech, and CRO clients with rapid patient insights from a proprietary panel of 120,000+ verified patients across cardiometabolic conditions including diabetes and obesity.
- Company typePrivate
- Founded2017
- HeadquartersCleveland, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Thrivable does
Thrivable, Inc. is a privately held B2B SaaS company headquartered in Bedford Heights, Ohio (Cleveland area), operating a real-time healthcare market research platform that connects pharmaceutical, medical device, and contract research organization (CRO) clients with a proprietary panel of 120,000+ verified patients across cardiometabolic conditions (diabetes, obesity, and related health conditions). The platform combines a curated patient database with screening and recruitment tools, survey execution capabilities, and an add-on HCP (healthcare professional) research community to deliver patient and provider insights — typically within two weeks — for use cases spanning brand performance evaluation, product adoption analysis, clinical study recruitment, and device strategy refinement. Technology components include patient profile and verification systems, targeted recruitment logic, multi-method survey deployment (online, phone, video focus groups, in-person product testing), and generative AI-assisted content and graphics generation for client deliverables.
The company operates a hybrid revenue model combining enterprise SaaS subscriptions (custom pricing, multi-year Service Orders) with usage-based fees for specific research projects and patient recruitment services, sold through a sales-led enterprise field motion targeting commercial leaders in pharma, medtech, and CROs. Thrivable has reported 700+ projects delivered over seven years of operation with a 75+ Net Promoter Score, and its named customer base includes Medtronic, Tandem Diabetes Care, Diabeloop, American Diabetes Association, Adhera Health, Y-Prime, and Magnolia Innovation. The company has raised approximately $8.1 million in venture funding across rounds in 2019, 2021, and December 2023, with the most recent $6 million Series A led by North Coast Ventures and joined by FCA Venture Partners, Jumpstart Ventures, and Tamarind Hill. Leadership is founder-led by David Edelman (previously founder of Diabetes Daily, acquired by Everyday Health), supported by an executive team covering operations, research, product, marketing, customer success, business development, and finance.
Thrivable firmographics
Firmographics- Name
- Thrivable
- Legal name
- Thrivable, Inc.
- Website
- https://thrivable.app
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Thrivable is a B2B SaaS healthcare market research platform serving pharma, medtech, and CRO clients with rapid patient insights from a proprietary panel of 120,000+ verified patients across cardiometabolic conditions including diabetes and obesity.
- Ownership category
- akta.pro rank
Where Thrivable is headquartered
LocationHeadquarters
- HQ city
- Cleveland
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Thrivable business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Platform Subscription and Research Services: B2B SaaS revenue model providing healthcare companies access to Thrivable's patient insights platform. Companies subscribe to access patient panels, conduct surveys, and receive research findings. Revenue is generated through subscription fees for platform access plus fees for specific research projects and patient recruitment services. The platform enables pharma and medtech companies to rapidly gather patient insights for commercial decisions, product development, and clinical research.
- HCP Research Panel Services: Separate revenue stream from recruiting and engaging healthcare professionals for research studies. HCPs participate in surveys, interviews, and panel discussions about diabetes care, emerging therapies, patient adherence, and treatment decision-making. Compensation to HCPs (up to $500 per activity) is passed through as a service cost to clients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise subscription with custom pricing based on research scope and volume |
| Usage-based | Pay-as-you-go | Per-project research services with variable scope |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Thrivable product offering
Product offeringCore offering
Thrivable is a B2B SaaS healthcare market research platform that connects pharmaceutical, medtech, and contract research organization (CRO) clients with a proprietary panel of 120,000+ verified patients across cardiometabolic conditions. The platform enables rapid patient insights delivery (as little as two weeks) through online surveys, phone surveys, video-based focus groups, and in-person product testing, supported by a separate Healthcare Provider (HCP) research community and patient screening and recruitment tooling.
Product overview
Thrivable is a B2B SaaS platform providing real-time market research services for healthcare organizations. The core offering is the Thrivable Rapid Research Platform, which connects companies with proprietary patient panels (120,000+ patients) and healthcare professional communities for rapid surveys and user engagement. The platform offers targeted solutions for Pharma Commercial Leaders, MedTech Innovators, and CROs, enabling healthcare teams to gather patient insights in as little as two weeks. The ecosystem includes specialized panels for both patients and healthcare professionals, along with a Findings Friday newsletter for ongoing insights delivery.
Differentiator
Problem solved
Functional benefit
Products and services
- Thrivable Rapid Research Platform A B2B SaaS platform that connects pharmaceutical, medtech, and contract research organization (CRO) clients with a proprietary panel of 120,000+ verified patients across cardiometabolic conditions, enabling online surveys, phone surveys, video-based focus groups, and in-person product testing with insights delivered in as little as two weeks. Targeted at enterprise healthcare commercial leaders, market research professionals, and product/clinical research teams.
- Patient Panel Services A distinct research service offering access to Thrivable's proprietary database of 120,000+ verified patients across cardiometabolic conditions (diabetes, obesity, and related health conditions) who participate in market research studies on behalf of healthcare companies. Enables rapid recruitment and engagement of targeted patient subsets for research activities.
- HCP Research Community A specialized research community for healthcare professionals (physicians, nurse practitioners, physician assistants, nurses, pharmacists, and allied health professionals with experience in diabetes care and related devices) who participate in surveys, interviews, and panel discussions on diabetes care, emerging therapies, patient adherence, and treatment decision-making. Participants are compensated (up to $500 per activity) with costs passed through to enterprise clients.
Quantifiable outcome
- 700+ projects delivered in diabetes and obesity across pharma and medtech
- +3 more outcomes
Companies that use Thrivable
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
Thrivable technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
Thrivable partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- TremendouscoreThrivable partners with Tremendous, a rewards and incentive platform, to compensate panel members for participating in research studies. Members earn points or gift cards redeemable through Tremendous, with rewards delivered via email from [email protected]. This partnership enables Thrivable to scale member compensation across its 120,000+ patient panel with automated reward fulfillment.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Thrivable competitors and assessment
Company assessmentDirect peers
- Within3: Within3 is a healthcare insights and stakeholder engagement platform serving life sciences companies with HCP and patient communities. Direct comparable on customer base (pharma/medtech), business model (SaaS + services), and use cases (qualitative/quantitative insights). Notable because Thrivable's new VP of BD (Peter Gannon) led global BD at Within3 from 2010-2024.
- Sermo: Sermo operates a global physician community and patient panel used by pharma for market research and HCP engagement. Directly comparable on physician/patient panel model, healthcare market research services, and pharma/medtech customer base. Peter Gannon also previously worked at Sermo.
- InCrowd (now Apollo Intelligence): Apollo Intelligence (parent of InCrowd) provides real-time market research to healthcare and life sciences clients through verified HCP and patient panels. Direct comparable on SaaS insights model and life sciences customer base; Thrivable board member Dan Fitzgerald was formerly CEO of Apollo Intelligence.
- Evidation Health: Evidation operates a large consented health measurement platform with millions of members, providing patient-generated health data and insights to life sciences. Comparable on patient community plus insights offering for pharma, though with a stronger consumer-health and wearable data orientation.
- Inspire: Inspire runs condition-specific patient communities and partners with life sciences on patient insights, real-world evidence, and clinical research recruitment. Comparable on the patient community + life sciences insights model; Thrivable's therapeutic-area specialization mirrors Inspire's vertical approach.
Broad incumbents
- Schlesinger Group: Schlesinger Group is a large, established market research data collection company serving consumer and healthcare buyers across qualitative and quantitative methodologies. Comparable as a healthcare market research incumbent with broader service breadth than Thrivable's panel-led SaaS model.
- Ipsos Healthcare: Ipsos is a global market research conglomerate with a dedicated healthcare practice covering pharma, biotech, medical devices, and patient outcomes. Comparable on healthcare market research focus, but at vastly larger scale and broader service portfolio including syndicated trackers.
- M3 (MDLinx / M3 Global Research): M3 operates a global physician panel and market research business serving pharma and healthcare. Comparable as a scaled healthcare insights platform with global reach that Thrivable aspires to compete with for cardiometabolic research spend.
Emerging players
- ZoomRx: ZoomRx provides pharma sales and marketing intelligence using physician panels and syndicated trackers. Comparable on physician panel-driven insights for pharma commercial teams, with a stronger focus on sales force and messaging analytics versus patient insights.
- Clinical Ink: Clinical Ink provides digital data capture and eCOA/ePRO solutions for clinical trials, with adjacent patient engagement capabilities. Partially comparable through patient data capture for life sciences, but focused on clinical trial outcomes rather than commercial market research.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Thrivable social profiles
Digital presenceThrivable compliance and trust
Trust signalCompliance1 record
Thrivable financial estimates
Financial estimateRevenue estimate
Valuation estimate
Thrivable leadership team
Management profileNumber of profiles
Profiles8 records
Thrivable funding detail
Funding detailFunding overview
Funding rounds4 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Thrivable M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Thrivable
What does Thrivable do?
Thrivable is a B2B SaaS healthcare market research platform that connects pharmaceutical, medtech, and contract research organization (CRO) clients with a proprietary panel of 120,000+ verified patients across cardiometabolic conditions. The platform enables rapid patient insights delivery (as little as two weeks) through online surveys, phone surveys, video-based focus groups, and in-person product testing, supported by a separate Healthcare Provider (HCP) research community and patient screening and recruitment tooling.
Is Thrivable a public or private company?
Thrivable is a private company. It is classified as venture growth investor backed and is currently operating.
When was Thrivable founded?
Thrivable was founded in 2017. It employs 11 to 50 people.
Where is Thrivable based?
Thrivable is headquartered in Cleveland, United States, in the North America region.
How does Thrivable make money?
Two revenue lines are on record. Platform Subscription and Research Services are the primary driver. The others are HCP Research Panel Services.
Who are Thrivable's main competitors?
Direct peers on record are Within3, Sermo, InCrowd (now Apollo Intelligence), Evidation Health and Inspire. Broad incumbents are Schlesinger Group, Ipsos Healthcare and M3 (MDLinx / M3 Global Research). Emerging players are ZoomRx and Clinical Ink.
Does Thrivable have an API?
No public API is recorded for Thrivable.